Ameriprise’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $905K | Buy |
96,674
+62,446
| +182% | +$585K | ﹤0.01% | 3284 |
|
|
2025
Q1 | $420K | Buy |
34,228
+2,246
| +7% | +$27.6K | ﹤0.01% | 3526 |
|
|
2024
Q4 | $423K | Sell |
31,982
-454,246
| -93% | -$6.01M | ﹤0.01% | 3561 |
|
|
2024
Q3 | $9.36M | Sell |
486,228
-34,852
| -7% | -$671K | ﹤0.01% | 1849 |
|
|
2024
Q2 | $10.7M | Buy |
521,080
+9,579
| +2% | +$197K | ﹤0.01% | 1686 |
|
|
2024
Q1 | $12.2M | Buy |
511,501
+5,492
| +1% | +$131K | ﹤0.01% | 1614 |
|
|
2023
Q4 | $10.9M | Buy |
506,009
+6,488
| +1% | +$140K | ﹤0.01% | 1697 |
|
|
2023
Q3 | $7.25M | Buy |
499,521
+143,600
| +40% | +$2.09M | ﹤0.01% | 1982 |
|
|
2023
Q2 | $7.45M | Buy |
+355,921
| New | +$7.45M | ﹤0.01% | 2034 |
|
|
2022
Q4 | – | Sell |
-276,731
| Closed | -$6.65M | – | 4034 |
|
|
2022
Q3 | $6.65M | Buy |
+276,731
| New | +$6.65M | ﹤0.01% | 2013 |
|
|
2020
Q3 | – | Sell |
-10,900
| Closed | -$162K | – | 3775 |
|
|
2020
Q2 | $162K | Sell |
10,900
-20,900
| -66% | -$311K | ﹤0.01% | 3528 |
|
|
2020
Q1 | $349K | Buy |
+31,800
| New | +$349K | ﹤0.01% | 3254 |
|